ARMISTICE CAPITAL LLC


Armistice Capital, LLC (“Armistice”), a Delaware limited liability company, is an investment management firm located in New York that commenced operations on May 1, 2012. Steven J. Boyd (the “Managing Member”) is Armistice’s principal and sole owner. Armistice provides discretionary investment advisory services to private investment funds (the “Funds”), which include: Armistice Capital Fund LP, a Delaware limited partnership that launched on July 1, 2012 (the “Domestic Fund”); Armistice Capital Offshore Fund Ltd., an exempted company incorporated under the laws of the Cayman Islands that launched on August 1, 2012 (the “Offshore Fund”); and Armistice Capital Master Fund Ltd., an exempted company incorporated under the laws of the Cayman Islands (the “Master Fund”) that launched on July 1, 2012; and serves as advisor to a separately managed account (the “Account” and together with the Funds, the “Advisory Clients”).

The Domestic Fund and the Offshore Fund invest substantially all of their assets in the Master Fund, through a master-feeder fund structure.

It should also be noted that Armistice Capital GP, LLC (the “General Partner”), an affiliate of Armistice, is also solely owned by Mr. Boyd and acts as General Partner to the Domestic Fund.

The Domestic Fund and the Offshore Fund, through their investments in the Master Fund, will seek to achieve long-term capital appreciation by employing an opportunistic global long/short strategy for investing in distressed debt, value equities and event equities. In all of its investing activities, the Funds will seek to emphasize capital preservation and will seek to mitigate risk through various hedging strategies at both the position and portfolio levels. To achieve this objective, the Funds will seek to focus on strategic value, event, and thematic investment opportunities (both long and short) in a variety of industries. It should be noted that the Funds invest a portion of their assets in illiquid investments (with some limitation), including, investments in securities of non-public companies.

While it is anticipated that the Funds will invest primarily in equities and equity-related securities in the both the U.S. and non-U.S. markets, Armistice has broad and flexible investment authority with respect to the Funds.

The Funds have entered into and may in the future enter into agreements ("Side Letters") with certain prospective or existing investors whereby such investors may be subject to terms and conditions that are more advantageous than those set forth in the respective Fund’s offering documents. The modifications are solely at the discretion of Armistice and may, among other things, be based on the size of the investor’s investment in the Funds, an agreement by an investor to maintain such investment in the Funds for a significant period of time, or other similar commitment by an investor to the Funds. The Managed Account’s investment objectives and the types of investments that such portfolio will hold are individually negotiated and established between Armistice and the Managed Account. As of December 31, 2018, Armistice manages approximately $1,466,209,000 of regulatory assets on a discretionary basis. please register to get more info

Open Brochure from SEC website
Assets
Pooled Investment Vehicles $2,019,674,000
Discretionary $2,019,674,000
Non-Discretionary $
Registered Web Sites

Related news

Cerecor Inc. (NASDAQ:CERC) Stock Position Lessened by Squarepoint Ops LLC

Squarepoint Ops LLC decreased its holdings in Cerecor Inc. (NASDAQ:CERC) by 28.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 25,472 shares of the company’s stock after selling 10,033 shares during the quarter.

Supernus Pharmaceuticals Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Seneca Biopharma Inc Registered Shs Stock , SNCA

© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...

3 Low Float Penny Stocks To Watch Before 2021 Up 70+% This Quarter

Armistice Capital, LLC reported a 14.2% stake in the company earlier this quarter. Furthermore, Morgan Stanley reported a 5.9% at the end of the 3rd quarter. Low Float Penny Stocks To Watch ...

Naked Brand Group Ltd.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Onconova Therapeutics Inc. Wt

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Synthetic Biologics Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Is BURL A Good Stock To Buy According To Hedge Funds?

Steven Boyd’s fund, Armistice Capital, also said goodbye to its stock, about $28.6 million worth. These moves are interesting, as aggregate hedge fund interest fell by 8 funds in the third quarter.

Is BURL A Good Stock To Buy According To Hedge Funds?

Steven Boyd’s fund, Armistice Capital, also said goodbye to its stock, about $28.6 million worth. These moves are interesting, as aggregate hedge fund interest fell by 8 funds in the third quarter.

Is ENTA A Good Stock To Buy Now According To Hedge Funds?

Armistice Capital, GLG Partners, and Millennium Management were also very fond of the stock, becoming one of the largest hedge fund holders of the company. In terms of the portfolio weights ...
Loading...
No recent news were found.